Skip to content
naulon
Not checkedNot checked for notices yet.

Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation

Giovanni Caocci, Sandra Atzeni, Monica Usai and 1 more

Leukemia Research Reports · 2018

doi:10.1016/j.lrr.2017.12.002 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

JAK2V617F mutation is found in about 60% of cases of essential thrombocytemia (ET) and represents a driving mutation. Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a low platelet (PLT) count. So far, only 2 reports described ET following ITP. For the first time we analyzed in a patient the JAK2V617F allele burden at ITP onset occurred 13 years before the ET diagnosis and found the presence of a small clone JAK2V617F positive clone (3%) raised to 27% in the following years. The association of ET and ITP could suggest similar pathogenetic mechanisms that should be further investigated. Keywords: Essential thrombocytemia, Immune thrombocytopenia, JAK2V617F mutation

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.